Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:47 PM
Ignite Modification Date:
2025-12-24 @ 5:47 PM
NCT ID:
NCT05889468
Eligibility Criteria:
Inclusion Criteria:
* 18 years of age and older
* English-speaking
* postpartum
* have met USPSTF recommendations for low-dose aspirin use during pregnancy: \>1 high risk factor (history of preeclampsia in prior pregnancy, multifetal gestational, chronic hypertension, preexisting diabetes, renal disease, autoimmune disease) or \>2 moderate risk factors (nulliparity, obesity, family history of preeclampsia, sociodemographic characteristics, age 35 years or older, or personal history factors) and reported at least 50% compliance with aspirin during pregnancy.
Exclusion Criteria:
* hypersensitivity reaction to aspirin or other salicylates,
* history of gastrointestinal bleeding
* history of gastric or duodenal ulcers
* severe hepatic dysfunction
* bleeding disorders and diathesis
* known cardiac dysfunction with reduced ejection fraction, or are taking or prescribed ACE inhibitors.
* Patients who required ICU level care during their pregnancy will be excluded.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT05889468
Study Brief:
Protocol Section:
NCT05889468